Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

  • Post date May 10, 2022 — 10:07 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000423 000538 000739 000963 000999 002223 002412 002432 002527 002603 002727 002773 002873 002932 300003 300026 300147 300151 300198 300376 300482 300725 Andon Health Apeloa Pharmaceutical Beijing Tongrentang Chengdu Kanghong Pharmaceutical Group China Resources Sanjiu Medical & Pharmaceutical Dashenlin Pharmaceutical Group Dong-E-E-Jiao Getein Biotech Henan Lingrui Pharmaceutical Huadong Medicine Hubei Jumpcan Pharmaceutical Hunan Hansen Pharmaceutical Jiangsu Kanion Pharmaceutical Jiangsu Yuyue Medical Equipment & Supply Jianmin Pharmaceutical Group Kpc Pharmaceuticals Shandong Buchang Pharmaceuticals Shijiazhuang Yiling Pharmaceutical Tasly Pharmaceutica Group Tianjin Zhongxin Pharmaceutical Group Corporation Yifeng Pharmacy Chain Yixintang Pharmaceutical Group Yunnan Baiyao Group Zhangzhou Pientzehuang Pharmaceutical Zhejiang Shouxiangu Pharmaceutical Science, Technology Health, Beauty Product Pharmaceutical Construction, Property Retail Transport Securities Epidemic Medicine Traditional Chinese Medicine, Tcm People Workplace Health, Safety Government Biology Technology, Engineering Party Small, Medium Enterprise Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data